Phase 1 Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Healthy adults between 18 and 30 years old with no health conditions that would affect their participation
- Healthy adults aged 65 or older with no health conditions that would affect their participation
- People who are already scheduled to have a routine coronary angiography (a procedure to look at the heart's blood vessels)
- People who have been diagnosed with mild to moderate COPD (a lung condition that makes breathing difficult)
- People who have a specific type of high blood pressure affecting the lungs, known as idiopathic or heritable Group 1 pulmonary arterial hypertension
- People with Class I, II, or III heart failure symptoms as classified by the New York Heart Association (a standard medical rating system for heart failure severity — confirm with trial site)
- People who have been diagnosed with ongoing high blood pressure
Who may not be able to join:
- People with severe COPD, including those who need supplemental oxygen or have very significantly reduced lung function
- People with a history of heart attack
- People who have previously had a procedure to unblock heart arteries using a small tube or balloon (percutaneous coronary revascularisation)
- People who have previously had coronary artery bypass graft surgery (open-heart surgery to reroute blood around blocked arteries)
- People currently experiencing unstable chest pain (unstable angina)
- People with a history of a specific type of chest pain caused by artery spasms (variant angina)
- People whose heart pumps less than 50% of blood out with each beat (ejection fraction below 50%)
- People with significant kidney disease, based on a specific measure of kidney filtering ability falling below a certain level
- People for whom an MRI scan would be unsafe — for example, those with a pacemaker, certain metal implants, or certain types of heart valves
- People who are pregnant
- People with physical health conditions (other than COPD, pulmonary arterial hypertension, heart failure, or high blood pressure) that the trial investigator determines would prevent safe participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Russell Richardson, Ph.D., George E Wahlen VA Medical Center
Phone: 801-584-2522
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Limb Blood Flow
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.